These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28573892)

  • 1. Acute myeloid leukemia in the elderly: therapeutic options and choice.
    Webster JA; Pratz KW
    Leuk Lymphoma; 2018 Feb; 59(2):274-287. PubMed ID: 28573892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remission.
    Shallis RM; Podoltsev NA
    Curr Opin Hematol; 2021 Mar; 28(2):110-121. PubMed ID: 33394722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting initial treatment of acute myeloid leukaemia in older adults.
    Podoltsev NA; Stahl M; Zeidan AM; Gore SD
    Blood Rev; 2017 Mar; 31(2):43-62. PubMed ID: 27745715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Elderly Patients With Acute Myeloid Leukemia.
    Thomas X; Le Jeune C
    Curr Treat Options Oncol; 2017 Jan; 18(1):2. PubMed ID: 28144802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.
    Bouchacourt B; Hospital MA; Zemmour C; Rey J; d'Incan E; Charbonnier A; Mohty B; Saillard C; Bonnet S; Collignon A; Gelsi-Boyer V; Mozziconacci MJ; Blaise D; Vey N
    Ann Hematol; 2020 Apr; 99(4):773-780. PubMed ID: 32088745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.
    Yoon JH; Cho BS; Kim HJ; Kim JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Am J Hematol; 2013 Dec; 88(12):1074-81. PubMed ID: 23983148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
    Borlenghi E; Cattaneo C; Cerqui E; Archetti S; Bertoli D; Bellotti D; Gramegna D; Soverini G; Oberti M; Schieppati F; Pagani C; Passi A; Sciumé M; Farina M; Carbone C; Crippa C; Dalceggio D; Tucci A; Rossi G
    Hematol Oncol; 2020 Dec; 38(5):754-762. PubMed ID: 32950042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial therapy for acute myeloid leukemia in older patients: principles of care.
    Bhatt VR; Gundabolu K; Koll T; Maness LJ
    Leuk Lymphoma; 2018 Jan; 59(1):29-41. PubMed ID: 28573900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
    Ferrara F
    Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
    Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
    Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study.
    Wang L; Zhao N; Zhou L; Tong J; Xue L; Zhang L; Han Y; Wang X; Geng L; Tang B; Liu H; Zhu W; Cai X; Liu X; Zhu X; Sun Z; Zheng C
    Clin Interv Aging; 2022; 17():55-64. PubMed ID: 35082491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
    Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age].
    Savchenko VG; Parovichnikova EN; Afanas'ev BV; Gritsaev SV; Semochkin SV; Bondarenko SN; Troitskaia VV; Sokolov AN; Kuz'mina LA; Kliasova GA; Baranova OIu; Lapin VA; Konstantinova TS; Samoĭlova OS; Kaporskaia TS; Shatokhin SV
    Ter Arkh; 2014; 86(7):4-13. PubMed ID: 25314772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?
    Finn LE; Foran JM
    Curr Opin Hematol; 2016 Mar; 23(2):95-101. PubMed ID: 26825695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the treatment of older individuals with acute myeloid leukemia: 2014.
    Michaelis LC; Erba HP
    Curr Opin Hematol; 2015 Mar; 22(2):108-15. PubMed ID: 25603478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute myeloid leukemia of the elderly: recent progresses in therapy].
    Yamauchi T
    Rinsho Ketsueki; 2018; 59(6):735-740. PubMed ID: 29973453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
    Li WY; Wang Y; Chen SN; Qiu HY; Fu ZZ; Wu DP; Sun AN
    Leuk Lymphoma; 2018 Jul; 59(7):1652-1658. PubMed ID: 29043875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting maintenance therapy in acute myeloid leukemia with novel agents.
    Canaani J; Luger SM
    Curr Opin Hematol; 2016 Mar; 23(2):175-80. PubMed ID: 26766539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.